{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:17:56Z","timestamp":1779110276642,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bcp.2026.117812","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:10:21Z","timestamp":1771258221000},"page":"117812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IMB5023: Dual suppression of microtubule assembly and STAT3 signaling overcomes chemoresistance and activates antitumor immunity"],"prefix":"10.1016","volume":"247","author":[{"given":"Han-Yu","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Nan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Qun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9552-8411","authenticated-orcid":false,"given":"Yan-Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2026.117812_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2020.151075","article-title":"Microtubule-targeting agents and their impact on cancer treatment","volume":"99","author":"\u010cerm\u00e1k","year":"2020","journal-title":"Eur. J. Cell Biol."},{"issue":"610","key":"10.1016\/j.bcp.2026.117812_b0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd4811","article-title":"Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxel","volume":"13","author":"Scribano","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.117812_b0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.117812_b0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1158\/0008-5472.CAN-17-0577","article-title":"Metabolically stable tubulin inhibitor targets the colchicine binding site and overcomes taxane resistance","volume":"78","author":"Arnst","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117812_b0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2020.08.040","article-title":"A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity","volume":"495","author":"Du","year":"2020","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.bcp.2026.117812_b0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.cdd.4400656","article-title":"Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters","volume":"7","author":"Stephanou","year":"2000","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.bcp.2026.117812_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092459","article-title":"STAT3, the challenge for chemotherapeutic and radiotherapeutic efficacy","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.bcp.2026.117812_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020965","article-title":"Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.bcp.2026.117812_b0045","doi-asserted-by":"crossref","first-page":"17635","DOI":"10.1074\/jbc.M800109200","article-title":"Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells","volume":"283","author":"Bourguignon","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.117812_b0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CAD.0000000000000588","article-title":"Sodium butyrate increases P-gp expression in lung cancer by upregulation of STAT3 and mRNA stabilization of ABCB1","volume":"29","author":"Zhao","year":"2018","journal-title":"Anticancer Drugs"},{"issue":"2","key":"10.1016\/j.bcp.2026.117812_b0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1083\/jcb.200503021","article-title":"Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin","volume":"172","author":"Ng","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117812_b0060","doi-asserted-by":"crossref","first-page":"15289","DOI":"10.1038\/ncomms15289","article-title":"Stat3 regulates centrosome clustering in cancer cells via Stathmin\/PLK1","volume":"8","author":"Morris","year":"2017","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.bcp.2026.117812_b0065","doi-asserted-by":"crossref","first-page":"12349","DOI":"10.1074\/jbc.M807761200","article-title":"STAT3-stathmin interactions control microtubule dynamics in migrating T-cells","volume":"284","author":"Verma","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117812_b0070","doi-asserted-by":"crossref","first-page":"31472","DOI":"10.1038\/srep31472","article-title":"A novel nitrobenzoate microtubule inhibitor that overcomes multidrug resistance exhibits antitumor activity","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.117812_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191984","article-title":"A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway","volume":"13","author":"Gong","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2026.117812_b0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10637-021-01210-6","article-title":"IMB5036, a novel pyridazinone compound, inhibits hepatocellular carcinoma growth and metastasis","volume":"40","author":"Lv","year":"2022","journal-title":"Invest. New Drugs"},{"issue":"5","key":"10.1016\/j.bcp.2026.117812_b0085","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/mc.22600","article-title":"A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis","volume":"56","author":"Zheng","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2026.117812_b0090","doi-asserted-by":"crossref","unstructured":"S. Zhang, X. Chen, E. Jin, A. Wang, T. Chen, X. Zhang, J. Zhu, L. Dong, Y. Sun, C. Yu, Y. Zhou, Z. Fan, H. Chen, S. Zhai, Y. Sun, Q. Chen, J. Xiao, S. Song, Z. Zhang, Y. Bao, Y. Wang, W. Zhao, The GSA Family in 2025: A Broadened Sharing Platform for Multi-omics and Multimodal Data, Genomics, proteomics & bioinformatics 23(4) (2025).","DOI":"10.1093\/gpbjnl\/qzaf072"},{"key":"10.1016\/j.bcp.2026.117812_b0095","unstructured":"Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2026, Nucleic acids research 54(D1) (2026) D28-d47."},{"key":"10.1016\/j.bcp.2026.117812_b0100","doi-asserted-by":"crossref","unstructured":"K.C. Chua, N. El-Haj, J. Priotti, D.L. Kroetz, Mechanistic insights into the pathogenesis of microtubule-targeting agent-induced peripheral neuropathy from pharmacogenetic and functional studies, Basic & clinical pharmacology & toxicology 130 Suppl 1(Suppl 1) (2022) pp. 60-74.","DOI":"10.1111\/bcpt.13654"},{"issue":"17","key":"10.1016\/j.bcp.2026.117812_b0105","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1158\/0008-5472.CAN-15-3116","article-title":"Structural basis for induction of peripheral neuropathy by microtubule-targeting cancer drugs","volume":"76","author":"Smith","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.117812_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040958","article-title":"PC12 cell line: cell types, coating of culture vessels, differentiation and other culture conditions","volume":"9","author":"Wiatrak","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bcp.2026.117812_b0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12575-010-9029-5","article-title":"Quick and simple detection technique to assess the binding of antimicrotubule agents to the colchicine-binding site","volume":"12","author":"Fortin","year":"2010","journal-title":"Biol. Proced. Online"},{"issue":"2","key":"10.1016\/j.bcp.2026.117812_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020603","article-title":"The multifaced role of STAT3 in cancer and its implication for anticancer therapy","volume":"22","author":"Tolomeo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.bcp.2026.117812_b0125","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/1878-0261.13263","article-title":"Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis","volume":"16","author":"Li","year":"2022","journal-title":"Mol. Oncol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117812_b0130","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3253","article-title":"Microtubule-binding agents: a dynamic field of cancer therapeutics","volume":"9","author":"Dumontet","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bcp.2026.117812_b0135","doi-asserted-by":"crossref","first-page":"e5976","DOI":"10.1371\/journal.pone.0005976","article-title":"Plk1-dependent recruitment of gamma-tubulin complexes to mitotic centrosomes involves multiple PCM components","volume":"4","author":"Haren","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2026.117812_b0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2011.11.023","article-title":"Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells","volume":"142","author":"Zhang","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bcp.2026.117812_b0145","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1124\/mol.110.066316","article-title":"Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signaling","volume":"78","author":"Walker","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117812_b0150","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/dna.2014.2713","article-title":"STAT3 association with microtubules and its activation are independent of HDAC6 activity","volume":"34","author":"Yan","year":"2015","journal-title":"DNA Cell Biol."},{"issue":"7","key":"10.1016\/j.bcp.2026.117812_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158440","article-title":"MPT0B098, a microtubule inhibitor, suppresses JAK2\/STAT3 signaling pathway through modulation of SOCS3 stability in oral squamous cell carcinoma","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bcp.2026.117812_b0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbrc.2013.04.087","article-title":"Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells","volume":"435","author":"Han","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.117812_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"44","key":"10.1016\/j.bcp.2026.117812_b0170","doi-asserted-by":"crossref","first-page":"27448","DOI":"10.18632\/oncotarget.25422","article-title":"Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. results from the proof-of-concept VICTOR-0 study","volume":"9","author":"Cerrito","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.117812_b0175","doi-asserted-by":"crossref","unstructured":"M. Locke, N. Kohn, N. Seetharamu, Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 48(6) (2023) pp. 915-919.","DOI":"10.1111\/coa.14091"},{"key":"10.1016\/j.bcp.2026.117812_b0180","article-title":"Efficacy and safety of low-dose nab-paclitaxel plus Tislelizumab in elderly patients with previously treated metastatic non-small cell lung cancer","volume":"12","author":"Zhu","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:03:04Z","timestamp":1779109384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"alternative-id":["S0006295226001437"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117812","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IMB5023: Dual suppression of microtubule assembly and STAT3 signaling overcomes chemoresistance and activates antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117812"}}